Physician profile
Marysol Thomas
NPI 1720449697
$830.92
in general payments reported to CMS, 2019-2025
10 companies · $125 in 2025
The $125 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $148 · 2022: $105 · 2023: $424 · 2024: $28.63 · 2025: $125.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $578.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $578.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $392.37 | 2021-2023 | Xarelto |
| Boston Scientific Corporation | $142.17 | 2023 | Varithena Administration Pack |
| Tactile Systems Technology INC | $99.68 | 2022-2025 | Flexitouch Plus, Nimbl, Entre Plus |
| E.R. Squibb & Sons, L.L.C. | $61.21 | 2022-2023 | Eliquis |
| Smith+Nephew, INC. | $35.44 | 2025 | Collagenase Santyl, Renasys Touch, Pico 14 |
| Silk Road Medical, INC. | $28.63 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Cvrx, INC. | $24.03 | 2025 | Barostim Neo System |
| Novo Nordisk INC | $17.82 | 2025 | Ozempic |
| Koya Medical, INC. | $16.50 | 2025 | Koya Medical, Dayspring |
| Abbvie INC. | $13.07 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marysol Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.